| BIIB Technical Analysis Data | ||||||||||||||||
Also see: |
41.53| BIIB Current Stock Quote |
Quotes delayed 20 minutes  Free BIIB Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| BIIB Stock Price Chart |
| BIIB Technical Analysis Charts |
  |
|
|
| About Biogen Inc |
| Biogen Inc. is a biopharmaceutical company dedicated to developing advanced therapies for serious diseases. Its portfolio includes treatments for multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). Key products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for MS; SPINRAZA for SMA; SKYCLARYS for Friedreich's Ataxia; QALSODY for ALS; and FUMADERM for severe plaque psoriasis. Co. also collaborates on LEQEMBI, ZURZUVAE, RITUXAN, GAZYVA, OCREVUS, LUNSUMIO and COLUMVI, and commercializes biosimilars such as BENEPALI, IMRALDI, FLIXABI and BYOOVIZ. When researching a stock like Biogen, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from BIIB Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for BIIB stock — the real life supply and demand for the stock over time — and examines that data in different ways. |
| BIIB Technical Analysis Charts |
  |
| Video: Technical Analysis | |
|
Video: Technical Analysis
| BIIB Technical Analysis Peers |
| Biogen (BIIB) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:
BMY Technical Analysis BSX Technical Analysis CAH Technical Analysis CI Technical Analysis CNC Technical Analysis COO Technical Analysis COR Technical Analysis CRH Technical Analysis CRL Technical Analysis CVS Technical Analysis More Healthcare companies » |
BIIB Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2026, All Rights Reserved
Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.